Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

The first AI-guided toxicity atlas for safer and more effective abdominal radiation therapy

Project description

Making radiotherapy safer with AI

Despite radiotherapy (RT) being crucial for about half of all cancer patients, fewer than 80 % in Europe receive it. This is largely due to fears of serious side effects. RT can damage healthy tissues near tumours, sometimes fatally, as seen in a major lung cancer trial where heart damage outweighed tumour control. In this context, the ERC-funded AIDose project aims to tackle this. By combining AI and advanced medical imaging, AIDose will build the first toxicity risk atlas for organs in the chest and abdomen. This 3D map will identify the most vulnerable organ subregions, helping oncologists tailor treatment more safely. The project could revolutionise how doctors predict and prevent radiation harm in cancer care.

Objective

Radiotherapy (RT) is a critical component of cancer treatment, potentially benefiting approximately 50% of patients. However, less than 80% of patients who could benefit from RT actually receive it in Europe. The risk of toxicities, i.e. the radiation-induced damage of healthy tissues, is one of the main reasons why oncologists may exclude a potentially beneficial RT from the treatment regimen. For example, a recent analysis of the RTOG 0617 trial highlighted that the tumor control benefits of high-dose lung RT are accompanied by higher mortality rates due to extensive heart irradiation. The AIDose project will leverage my work on hepatobiliary toxicity prediction, artificial intelligence (AI) advancements, and medical image analysis to develop the first toxicity risk atlas for thoracic and abdominal organs-at-risk (OARs), i.e. organs located in close proximity to tumors. The atlas is envisioned as a three-dimensional map of OARs with pinpointed anatomical subregions associated with high toxicity risks. The AIDose project has four aims: a) developing AI-driven solutions for morphological and radiomic profiling of OARs; b) extracting and analyzing non-dosimetric clinical features associated with toxicities; c) utilizing AI to identify consistent patterns in radiation doses delivered to OAR subregions, and correlating them with toxicity risks; d) validating the resulting toxicity atlas against multi-hospital RT data. The feasibility of AIDose is supported by my previous research on liver and head-and-neck RT planning, which resulted in publications in key journals in the field and an award from the American Association of Medical Physicists. The use of AI for radiotherapy planning and outcome prediction is believed to be the main area of impact by the American and European Societies for Radiation Oncology. This proposal represents a unique opportunity to advance this highly innovative and clinically important research direction.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-COG

See all projects funded under this call

Host institution

KOBENHAVNS UNIVERSITET
Net EU contribution
€ 1 999 972,75
Address
NORREGADE 10
1165 KOBENHAVN
Denmark
Region
Danmark Hovedstaden Byen København
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 999 972,75

Beneficiaries (1)